Nautilus Biotechnology
Nick Brazell is an experienced accounting professional currently serving as the External Reporting and Technical Accounting Manager at Nautilus Biotechnology since August 2022. Prior to this role, Nick held the position of Financial Reporting Manager at Silverback Therapeutics from March 2021 to August 2022. Nick's career began at EY, where a progression of roles from Audit Intern to Audit Manager occurred between June 2014 and February 2021. Additionally, Nick gained experience as a State & Local Tax Intern at Weyerhaeuser in 2013. Nick holds a Bachelor of Arts in Accounting from Seattle University, earned in 2014.
This person is not in any offices
Nautilus Biotechnology
Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the human proteome. They are driven to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across biomedical research and drug discovery.